Marker Therapeutics
$2.799876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.79
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.06 (+2.20%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours
Why Robinhood?
You can buy or sell MRKR and other stocks, options, ETFs, and crypto commission-free!
About MRKR
Marker Therapeutics, Inc. Common Stock, also called Marker Therapeutics, is a clinical-stage immuno-oncology company, which specializes in the development and commercialization of novel cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Read More The company was founded on October 22, 1991 and is headquartered in Houston, TX.
Employees
11
Headquarters
Houston, Texas
Founded
1991
Market Cap
124.82M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
361.06K
High Today
$2.81
Low Today
$2.71
Open Price
$2.75
Volume
161.21K
52 Week High
$9.17
52 Week Low
$2.45
Collections
MRKR Earnings
-$0.13
-$0.09
-$0.04
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Mar 12, After Hours
People Also Bought
Viking Therapeutics
38,277
$6.65
-1.19%NIO
130,739
$3.91
+3.71%Geron
31,598
$1.31
+1.55%Cronos Group
191,872
$7.19
-2.04%Pareteum
29,185
$0.7799
+1.58%Inovio
55,523
$4.43
+6.75%Sorrento Therapeutics
12,022
$2.64
-2.94%TG Therapeutics
5,270
$15.86
+0.51%Verastem
17,386
$2.03
+1.50%Amarin
16,082
$18.25
+3.58%Cara Therapeutics
24,563
$17.19
-3.35%CannTrust
102,281